Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies
Abdallah Abou Zahr(Mount Sinai Beth Israel), John Mascarenhas(Tisch Hospital), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Nicole A. Carreau(Dana-Farber Cancer Institute), Srđan Verstovšek(Unknown), Ronald Hoffman(Icahn School of Medicine at Mount Sinai), Douglas Tremblay(Tisch Cancer Institute), R. A. Mesa(Mayo Clinic in Arizona)
Cited by 194
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
|Biology of Blood and Marrow Transplantation|2009|595
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484